NextPlat's ClearMetrX 4.0 to Enhance Healthcare Analytics with AI
NextPlat Corp has announced in a press release that its ClearMetrx subsidiary is in the late stages of developing ClearMetrX 4.0, an advanced healthcare data analytics and reporting software. This new version will feature AI-enhanced capabilities aimed at improving efficiency in healthcare operations and patient outcomes. The software is expected to be rolled out internally by the end of 2025, with commercial availability planned for the first half of 2026.
ClearMetrX 4.0 will integrate AI-powered features such as revenue forecasting, predictive inventory management, and anomaly detection. These enhancements are designed to streamline data analytics for various healthcare entities, including physicians and pharmacies. The platform will also offer AI-driven tools for fraud detection and compliance reporting, making it a comprehensive decision-support system for healthcare organizations.
The global AI in healthcare market is projected to grow significantly, driven by the demand for enhanced efficiency and better patient outcomes. ClearMetrX 4.0 aims to meet these demands by providing a more streamlined way to collect, analyze, and operationalize healthcare data.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 12 Aignostics Opens Early Access to PathoSearch Sep 11 Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis Sep 11 UrgentIQ Raises $15 Million for AI Clinical Workflows Sep 11 Penguin Ai Launches Revenue Cycle AI Platform Sep 11 MegazoneCloud Builds Quality Assurance AI Agent for Hanmi PharmaceuticalLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Metriport Raises $26 Million for Patient Record Platform
TransformativeMed and Red Rover Health Partner on Agentic AI for Oracle Health EHR
Curitics Health Adds AI Tools for Clinical Workflows
CluePoints Releases Three AI Tools for Clinical Data Review
Cortechs.ai Gets FDA Clearance for NeuroQuant PET
Daily AI Brief: the AI news that matters, in your inbox.